Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.

Gabriel TorrensThomas Ewout van der SchalkSara Cortes-LaraLeen TimbermontEster Del Barrio-TofiñoBasil Britto XavierLaura ZamoranoChristine LammensOmar AliAlexey RuzinHerman GoossensSamir Kumar-SinghJan KluytmansFleur PalingR Craig MacLeanThilo KöhlerCarla López-CausapéSurbhi Malhotra-KumarAntonio Olivernull null
Published in: The Journal of antimicrobial chemotherapy (2022)
An overall high prevalence of resistance is documented European ICUs, but with a wide intercountry variability determined by the dissemination of XDR high-risk clones, arguing for the need to reinforce infection control measures.